| Primary |
| Urinary Tract Infection |
23.1% |
| Prophylaxis |
15.4% |
| Anxiety |
7.7% |
| Calcium Deficiency |
7.7% |
| Depression |
7.7% |
| Drug Use For Unknown Indication |
7.7% |
| Iron Deficiency |
7.7% |
| Nausea |
7.7% |
| Neoplasm Prostate |
7.7% |
| Pain |
7.7% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
14.4% |
| Prostate Cancer |
13.5% |
| Hiv Infection |
9.2% |
| Product Used For Unknown Indication |
7.9% |
| Hypertension |
6.1% |
| Ill-defined Disorder |
5.2% |
| Schizophrenia |
5.2% |
| Polycystic Ovaries |
4.8% |
| Urinary Tract Infection |
4.4% |
| Alcohol Use |
3.9% |
| Hormone Replacement Therapy |
3.9% |
| Antiretroviral Therapy |
2.6% |
| Arthritis |
2.6% |
| Dyspnoea |
2.6% |
| Foetal Exposure During Pregnancy |
2.6% |
| Hirsutism |
2.6% |
| Prophylaxis |
2.6% |
| Asthma |
2.2% |
| Androgenetic Alopecia |
1.7% |
| Contraception |
1.7% |
|
| Hepatitis Fulminant |
15.7% |
| Meningioma |
13.7% |
| Pulmonary Embolism |
11.8% |
| Cytolytic Hepatitis |
9.8% |
| Thrombocytopenia |
5.9% |
| Hepatitis Cholestatic |
3.9% |
| Malignant Neoplasm Progression |
3.9% |
| Nausea |
3.9% |
| Osteoporosis |
3.9% |
| Pyrexia |
3.9% |
| Renal Failure |
3.9% |
| Scrotal Haematoma |
3.9% |
| Decreased Appetite |
2.0% |
| Deep Vein Thrombosis |
2.0% |
| Duodenal Ulcer Haemorrhage |
2.0% |
| Epilepsy |
2.0% |
| Foot Fracture |
2.0% |
| Gamma-glutamyltransferase Increased |
2.0% |
| Gynaecomastia |
2.0% |
| Hepatic Steatosis |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.8% |
| Prostate Cancer |
18.9% |
| Drug Use For Unknown Indication |
13.9% |
| Alopecia |
8.8% |
| Glaucoma |
4.8% |
| Hypertension |
3.6% |
| Pain |
3.0% |
| Metastases To Bone |
2.5% |
| Chronic Lymphocytic Leukaemia |
2.3% |
| Prostate Cancer Metastatic |
2.3% |
| Depression |
2.1% |
| Diabetes Mellitus |
2.0% |
| Sarcoma Metastatic |
1.8% |
| Aggression |
1.6% |
| Erectile Dysfunction |
1.6% |
| Hiv Infection |
1.3% |
| Hyperandrogenism |
1.3% |
| Metastatic Renal Cell Carcinoma |
1.3% |
| Bipolar Disorder |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Pneumonia |
14.5% |
| Thrombocytopenia |
9.6% |
| Rhabdomyolysis |
6.0% |
| Syncope |
6.0% |
| General Physical Health Deterioration |
4.8% |
| Neutropenia |
4.8% |
| Prostate Cancer |
4.8% |
| Tachycardia |
4.8% |
| Weight Decreased |
4.8% |
| Cold Type Haemolytic Anaemia |
3.6% |
| Death |
3.6% |
| Decreased Appetite |
3.6% |
| Fall |
3.6% |
| Hypocoagulable State |
3.6% |
| Osteonecrosis |
3.6% |
| Osteonecrosis Of Jaw |
3.6% |
| Pulmonary Embolism |
3.6% |
| Rectal Haemorrhage |
3.6% |
| Respiratory Failure |
3.6% |
| Vomiting |
3.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
75.0% |
| Atrial Fibrillation |
20.0% |
| Convulsion |
5.0% |
|
| Cytolytic Hepatitis |
28.6% |
| Drug Interaction |
28.6% |
| Decreased Appetite |
14.3% |
| Prothrombin Time Ratio Decreased |
14.3% |
| Renal Failure |
14.3% |
|
